The U.S. patient population for Revuforj in its approved indication is roughly 2,000 according to Syndax. KMT2A leukemias ...

Richard Gerhold, DVM, MS, PhD, DACVM (Parasitology): So, the best way for treating mites or diagnosing mites is doing a really good physical exam: a thorough physical exam that includes looking from, ...

Revuforj is the first so-called menin inhibitor cleared in the U.S., securing FDA approval for use in adults and certain ...

Nov 18 (Reuters) - Johnson & Johnson's (JNJ.N), opens new tab drug for a type of skin condition met the main goals in a late-stage trial, the drugmaker said on Monday. The drug, icotrokinra, was ...

In his recent doctoral thesis, defended at the University of Helsinki, Matej Zore investigated two drugs, fingolimod and etrasimod—initially developed to treat autoimmune diseases—for their potential ...

Findings from a phase 3 trial with Blenrep, Velcade and dexamethasone in relapsed/refractory multiple myeloma will be ...